{"id":"W2116762906","doi":"10.1016/s0168-8278(11)61362-7","title":"1360 PEGYLATED INTERFERON-LAMBDA (PEGIFN-λ) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFNα-2A IN HCV PATIENTS (Gl/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12","year":2011,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Pegylated interferon; Medicine; Virology; Lambda; Interferon; Internal medicine; Immunology; Ribavirin; Gastroenterology; Hepatitis C virus; Adverse effect; Virus; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001175101,0.0005878368,0.00100727,0.0002666388,0.0002461153,0.0005649888,0.0004502424,0.0006871681,0.004407949],"category_scores_gemma":[0.000701302,0.0004308876,0.0007713858,0.0002373658,0.000569852,0.0007020369,0.0001972689,0.001765249,0.001037713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005409463,"about_ca_system_score_gemma":0.0005141929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008632911,"about_ca_topic_score_gemma":0.002205111,"domain_scores_codex":[0.9996858,0.0001738414,0.00001815569,0.00002659093,0.00002995669,0.00006583358],"domain_scores_gemma":[0.999676,0.00007225329,0.00005834128,0.00003161541,0.00001684002,0.0001449106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7726675,0.01278211,0.004323018,0.0002750773,0.0005624624,0.0001682165,0.0001665359,0.000681134,0.07402439,0.0002886943,0.003187209,0.1308737],"study_design_scores_gemma":[0.5017192,0.4194506,0.04259622,0.00007198661,0.000477742,0.0008292894,0.0001022555,0.00215126,0.02726298,0.0003126434,0.004964349,0.00006139224],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996101,0.001303508,0.0003487879,0.000303768,0.00006210689,0.0001873131,0.0003808037,0.0001019841,0.001210695],"genre_scores_gemma":[0.9939483,0.0008793669,0.001481283,0.0004307824,0.0001222112,0.000117743,0.0009603488,0.00004466952,0.002015251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004407949,"threshold_uncertainty_score":0.01474601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06030769208121305,"score_gpt":0.3323347836271172,"score_spread":0.2720270915459042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}